Alpha支架辅助弹簧圈栓塞治疗未破裂宽颈远端颈内动脉动脉瘤:6个月安全性与有效性
这项前瞻性单中心研究纳入50例患者共54个未破裂宽颈远端颈内动脉动脉瘤,评估Alpha支架辅助弹簧圈栓塞的安全性与有效性。主要有效性终点(成功栓塞且6个月MRA完全或近完全闭塞)见于94.4%(51/54)动脉瘤,6个月随访完全闭塞64.1%(34/53)、近完全闭塞32.0%(17/53),4%(2/50)患者发生严重不良事件。
要点
- 6个月主要有效性终点见于94.4%(51/54)动脉瘤。
- 53个使用Alpha支架治疗的动脉瘤中,完全闭塞64.1%、近完全闭塞32.0%。
- 4%(2/50)患者发生严重不良事件:视网膜动脉血栓栓塞和放射冠腔隙性梗死。
核心结论
- 对于未破裂宽颈远端颈内动脉动脉瘤的血管内治疗,使用新型Alpha支架辅助弹簧圈栓塞在有效性和安全性方面显示出良好的手术和中短期临床随访结果。
研究设计与样本
- 前瞻性单中心研究,2016年4月至2018年纳入50例患者(平均年龄56.5岁,女性45例[90%])共54个未破裂远端颈内动脉动脉瘤(平均直径5.6±1.7 mm)。
- 主要有效性终点为使用Alpha支架成功弹簧圈栓塞,并在6个月磁共振血管造影评估时达到完全或近完全闭塞。
- 主要安全性终点为术后至6个月无严重不良事件。
诊断标准与关键数值
- 主要有效性终点见于94.4%(51/54)动脉瘤。
- 1例因载瘤动脉迂曲支架无法释放而技术失败,改用其他类型支架。
- 53个使用Alpha支架治疗的动脉瘤中,6个月随访完全闭塞64.1%(34/53)、近完全闭塞32.0%(17/53)。
- 2例(3.7%)因主要复发需要再治疗。
- 4%(2/50)患者术后发生严重不良事件,分别为视网膜动脉血栓栓塞和放射冠腔隙性梗死。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The Alpha stent (CGBio), a new intracranial stent featuring a re-sheathable mesh design with improved wall apposition at the curved segment, was clinically evaluated. We report the 6-month follow-up results from a prospective, single-center study in which the stent was used for coiling of wide-necked distal internal carotid artery (ICA) aneurysms.
MATERIALS AND METHODS: Between April 2016 and 2018, 50 patients (mean age, 56.5 years, 45 females [90%]) with 54 unruptured distal ICA aneurysms (average diameter: 5.6 ± 1.7 mm) were enrolled. The primary endpoint for effectiveness was successful coil embolization with the Alpha stent, and subsequent complete or near-complete occlusion at the 6-month magnetic resonance angiography assessment. The primary safety endpoint was the absence of serious adverse events (SAEs) up to 6 months from the procedure.
RESULTS: The primary effectiveness endpoint was observed in 94.4% (51/54) aneurysms. In one patient with technical failure, the stent could not be deployed because of parent artery tortuosity; therefore, a different type of stent was used. Of the 53 aneurysms treated with the Alpha stent, complete occlusion was achieved in 64.1% (34/53) cases, and near-complete occlusion was achieved in 32.0% (17/53) cases by the 6-month follow-up. Two cases (3.7%) required retreatment because of major recurrence. In 4% (2/50) patients, SAEs, i.e., retinal artery thromboembolism and corona radiata lacunar infarction, were reported after the procedure.
CONCLUSION: For endovascular treatment of unruptured, wide-necked, distal ICA aneurysms, coil embolization using the newly developed Alpha stent showed excellent procedural and mid-term clinical follow-up results in terms of effectiveness and safety.
引用
- Song Y, Sheen JJ, Kim JG, et al. Alpha Stent for Coiling of Unruptured, Wide-Necked, Distal Internal Carotid Artery Aneurysms: Safety and Effectiveness at 6 Months. Korean J Radiol. 2020. PMID: 31997598. doi:10.3348/kjr.2019.0188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。